ArticleNature communications2019

Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease.

Edmund C Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.